Quantitative determination of oxybutynin hydrochloride by spectrophotometry, chemometry and HPTLC in presence of its degradation product and additives in different pharmaceutical dosage forms.
Simple, accurate, sensitive and validated UV spectrophotometric, chemometric and HPTLC-densitometric methods were developed for determination of oxybutynin hydrochloride (OX) in presence of its degradation product and additives in its pharmaceutical formulations. Method A is the first derivative of ratio spectra (DD(1)) which allows the determination of OX in presence of its degradate in pure form and tablets by measuring the peaks amplitude at 216 nm. Method B and C are principal component regression (PCR) and partial least-squares (PLS) for determination of OX in presence of its degradate in pure form, tablets and syrup. While, the developed high performance thin layer chromatography HPTLC-densitometric method was based on the separation of OX from its degradation product, methylparaben and propylparaben followed by densitometric measurement at 220 nm which allows the determination of OX in pure form, tablets and syrup. The separation was achieved using HPTLC silica gel F(254) plates and chloroform:methanol:ammonia solution:triethylamine (100:3:0.5:0.2, v/v/v/v) as the developing system. The accuracy, precision and linearity ranges of the developed methods were determined. The results obtained were statistically compared with each other and to that of a reported HPLC method, and there was no significant difference between the proposed methods and the reported method regarding both accuracy and precision.
Analytical Chemistry Department, Faculty of Pharmacy, Beni-Suef University, Egypt.
Nour E
NE
Wagieh
Maha A
MA
Hegazy
M
M
Abdelkawy
Eglal A
EA
Abdelaleem
D002855:Chromatography, Thin Layer / Q000191:economics / Q000379:methods*; D003720:Densitometry / Q000191:economics / Q000379:methods*; D004304:Dosage Forms; D016018:Least-Squares Analysis; D057230:Limit of Detection; D008333:Mandelic Acids / Q000032:analysis* / Q000737:chemistry; D025341:Principal Component Analysis; D015203:Reproducibility of Results; D013053:Spectrophotometry / Q000191:economics / Q000379:methods*
D004304:Dosage Forms; D008333:Mandelic Acids; C005419:oxybutynin